SgRNA for targeted knockout of chicken PPAR gamma gene as well as vector and application of sgRNA
By designing the sgRNA and CRISPR/Cas9 system targeting the chicken PPARγ gene, combined with the HITI method and red fluorescent marker, the problems of low knockout efficiency of chicken PPARγ gene and cumbersome cell screening in the existing technology have been solved, and efficient gene editing and simplification have been achieved. The screening process deeply studied the fat-generating mechanism of broiler chickens.
Patent Information
- Application Number
- CN202411320227.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-23
- Publication Date
- 2024-11-08
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing chicken PPARγ gene knockout method is inefficient and inaccurate, which makes it difficult to study adipogenesis. Knockout of large genome fragments affects the regulation of other gene expression, and cell screening is cumbersome and time-consuming.
Design a sgRNA and its vector that targets the knockout chicken PPARγ gene, combined with the CRISPR/Cas9 system, insert reporter mCherry into the second exon through the HITI method, realize efficient gene editing and successfully edited through red fluorescent marker detection, saving Time and expenses.
The gene editing efficiency of 75.4% was achieved, the production of other new proteins was avoided, the cell screening process was simplified, and the role of PPARγ in fat production was studied in depth, laying the foundation for molecular breeding of low-fat broilers.
Smart Images

Figure CN118910058A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the biological field, and in particular relates to a sgRNA for targeted knockout of a chicken PPARγ gene, and a vector and application thereof. Background Art
[0002] Chicken is not only an important economic animal, but also an important animal model for research in developmental biology and immunology. In the current broiler industry, due to long-term genetic selection, the growth rate and meat production of broilers have been significantly improved, but this is accompanied by excessive fat accumulation in broilers, especially excessive fat accumulation in the abdomen. Excessive fat accumulation will lead to decreased feed conversion efficiency, reduced meat quality, reduced economic benefits of chicken farming companies, and decreased consumer purchasing desire. Therefore, understanding the molecular mechanism of broiler fat production and fat growth and development, reducing excessive abdominal fat deposition, and creating new low-fat broiler breeds have become one of the goals of broiler breeding development.
[0003] The PPARγ gene is located on chicken chromosome 12 and encodes two protein isoforms (PPARγ1 and PPARγ2). It is the most important key transcription factor for adipogenesis known to date. In vitro functional analysis found that PPARγ plays a key regulatory role in adipocyte differentiation. Overexpression of PPARγ in fibroblasts or myocytes can promote the transdifferentiation of these two cells into adipocytes. In 3T3-L1 adipocytes, silencing PPARγ leads to adipocyte dedifferentiation and lipid reduction, as well as decreased expression of mature adipocyte marker genes. In vivo studies have shown that complete knockout of PPARγ can lead to placental dysfunction and embryonic lethality in mice. In order to study the role of PPARγ in adipogenesis, adipose-specific PPARγ knockout mice were constructed. Adipose tissue-specific PPARγ knockout mice can still form adipose tissue, but the mice have reduced white fat and brown fat, reduced expression of adipocyte marker genes, reduced fat pad size in adipose and liver, and insulin resistance. Our previous studies have found that the chicken PPARγ gene also plays an important role in adipogenesis. Overexpression of PPARγ can inhibit the proliferation of chicken preadipocytes and promote preadipocyte differentiation; knocking out the PPARγ gene can promote the proliferation of chicken preadipocytes and inhibit preadipocyte differentiation. Therefore, targeting the expression level of the PPARγ gene in chickens is a potential means to control excessive abdominal fat accumulation in broiler chickens.
[0004] At present, with the in-depth study of gene function and regulation, people have realized that simple gene knockout cannot accurately analyze gene function, gene interaction and gene regulatory network, but it is necessary to establish tissue and cell-specific gene knockout, inducible knockout, gene-specific labeling (tracing), precise base replacement or deletion and other technologies. CRISPR / Cas9 system has been widely used in the preparation of mutants such as indel and gene knock-in. There are two main knock-in methods of CRISPR / cas9, namely non-homologous end joining (NHEJ) and homologous recombination (homology-directed repair, HDR). The HDR repair pathway mainly occurs in the S phase and G2 phase of the cell cycle, and NHEJ repair occurs in all stages of the cell cycle. Therefore, the integration efficiency of the NHEJ method is significantly higher than that of HDR. The HITI (homology-independent targeted integration) method is an NHEJ-mediated integration method with high integration efficiency. It achieves in vivo linearization by adding guide sgRNA cutting sites that are opposite to the target site at both ends of the donor vector, and also greatly reduces reverse integration events. This method is widely used in mammalian gene knockout. At present, the gRNA for targeted knockout of the chicken PPARγ gene is designed in the fourth exon. This method does not affect the transcription and translation initiation of the PPARγ gene, but only causes a frameshift mutation inside the gene, resulting in the PPARγ gene only being able to express its N-terminal part (1-186aa). The other is a large-fragment knockout method of the PPARγ gene, which is inefficient, and the knockout of large genomic fragments will lead to the loss of some important genomic cis-regulatory elements, which will change the expression regulation of other genes and the stability of the genome. In these two methods of knockout of the chicken PPARγ gene, the screening of knockout cells is very cumbersome, and PCR amplification of target sequence fragments and cloning sequencing are required to identify the knockout cells, which is time-consuming and laborious. Summary of the invention
[0005] Based on the above shortcomings, the present invention provides a sgRNA for targeted knockout of chicken PPARγ gene and its vector and application.
[0006] To achieve the above object, the present invention is specifically implemented through the following technical solution: a sgRNA for targeted knockout of chicken PPARγ gene, the sgRNA nucleotide sequence is shown in SEQ ID No.1.
[0007] Furthermore, the present invention also provides a recombinant vector, which comprises the sgRNA as described above.
[0008] Furthermore, the recombinant vector is a cas9 / gRNA vector.
[0009] Furthermore, the present invention also provides the use of the sgRNA or the recombinant vector described above in targeted knockout of the chicken PPARγ gene.
[0010] Another object of the present invention is to provide a method for constructing a chicken PPARγ gene mutant cell line containing a red fluorescent protein marker. The method uses the CRISPR / Cas9 system to knock in the red fluorescent protein mCherry while knocking out the PPARγ gene. Then, whether the cell is successfully edited can be detected by observing whether the cell expresses red fluorescence, which saves time and cost for the subsequent detection of PPARγ gene-edited cells. The construction method steps are as follows:
[0011] S1. According to the sgRNA sequence for knocking out the chicken PPARγ gene, a reverse complementary nucleotide chain is designed and the two are mixed and annealed to form a double chain. The sgRNA nucleotide sequence is shown in SEQ ID No. 1;
[0012] S2, connecting the double strand to the poultry cas9 / gRNA vector to obtain a recombinant vector;
[0013] S3, using the mCherry-puro plasmid as a template, using the primer set HITI-F / R for PCR amplification, wherein the nucleotide sequences of the primer set HITI-F / R are shown in SEQ ID No.2 and SEQ ID No.3, respectively, and the PCR amplification product is gel-purified and then connected to the pEASY-Blunt vector to obtain a donor vector;
[0014] S4. Co-transfect the recombinant vector and the donor vector into chicken-derived cells, and obtain a chicken PPARγ gene knockout cell line containing a red fluorescent marker through culture, screening and identification.
[0015] Furthermore, in step S4 as described above, flow cytometry screening is performed using red fluorescence.
[0016] Furthermore, the present invention also provides a chicken PPARγ gene knockout cell line containing a red fluorescent marker obtained by the construction method described above.
[0017] Furthermore, the present invention also provides the use of a cell line as described above for specifically marking or tracing PPARγ gene knockout cells when preparing gene-edited chickens.
[0018] Advantages and beneficial effects of the present invention: the gRNA of the present invention is designed in the second exon, and since a reporter gene is inserted into the genome, PPARγ can be knocked out without causing other new proteins to be produced easily, and the gene editing efficiency is 75.4%. In addition, the present invention uses the CRISPR / Cas9 system to knock in mCherry (red fluorescent protein) in a targeted manner and knocks out the PPARγ gene at the same time, so that whether the cell is successfully edited can be detected by observing whether the cell expresses red fluorescence, thereby realizing specific marking of genes or cells; the present invention has the advantages of saving time and cost, and lays a foundation for in-depth research on the role and mechanism of the PPARγ gene in chicken fat generation and fat growth and development, and is conducive to further analyzing the genetic mechanism of abdominal fat deposition in broiler chickens and the molecular breeding of high-quality low-fat broiler chickens. BRIEF DESCRIPTION OF THE DRAWINGS
[0019] Figure 1 This is the sequencing map of VK001-08-sgRNA plasmid;
[0020] Figure 2 This is the electrophoresis diagram of the product of PCR amplification of gRNA-EF1α-puro-mCherry-polyA fragment, where M is 5KDNA marker, and the sizes of the maker bands from top to bottom are: 5000bp, 3000bp, 2000bp, 1500bp, 1000bp, 800bp, 500bp, 300bp;
[0021] Figure 3 This is the sequencing map of the donor vector pEASY-Blunt-gRNA-EF1α-puro-mCherry-polyA plasmid;
[0022] Figure 4 These are images of PPARγ gene-edited cells, including (a) a bright field image of PPARγ gene-edited cells, and (b) a fluorescent field image of PPARγ gene-edited cells;
[0023] Figure 5 This is the electrophoresis diagram of the product of PCR identification of the donor fragment inserted into the PPARγ genome, where M is the 2KDNA marker, and the sizes of the maker bands from top to bottom are: 2000bp, 1000bp, 750bp, 500bp, 200bp, and 100bp. 1 is the PCR identification of the insertion of the donor fragment at the 5' junction; 2 is the PCR identification of the insertion of the donor fragment at the 3' junction;
[0024] Figure 6 The sequence diagram of the donor fragment inserted into the PPARγ genome; wherein, (a) is the sequencing result of the 5' junction, and (b) is the sequencing result diagram of the 3' junction;
[0025] Figure 7 This is a picture of Western blotting to identify PPARγ gene-edited cells, where 1 is a wild-type cell and 2 is a PPARγ gene-edited cell. DETAILED DESCRIPTION
[0026] The present invention is further described below with reference to the accompanying drawings:
[0027] Example 1
[0028] 1. Screening of efficient gRNA targeting PPARγ exon
[0029] 1. Design of sgRNA
[0030] Through NCBI ( https: / / www.ncbi.nlm.nih.gov ) website to download the chicken PPARγ gene sequence, determine the second exon sequence of PPARγ, and design the nucleotide sequence of the sgRNA target site as shown in SEQ ID No. 1 (as shown in Table 1). According to the instructions of the VK001-08 vector of the CRISPR / Cas9 gene editing system (Beijing Weishanglide Biotechnology Co., Ltd.), bases were added to both ends of the sense strand and the antisense strand to complement the sticky ends of the cas9 / sgRNA vector.
[0031] Table 1 Nucleotide sequences of sgRNA target sites
[0032] name sgRNA sequence (5'-3') PAM Sequence Number of bases Serial Number sgRNA GCTATTGAATGTCGTGTGTG TGG 20 SEQ ID No.1 2. Construction of VK001-08-sgRNA vector
[0033] 2.1. Anneal the sgRNA primers to form oligo primer dimers, and then insert the oligo primer dimers into the VK001-08 vector to obtain the final product VK001-08-sgRNA.
[0034] 2.2. Take the product obtained in step 2.1 and add it to the thawed DH5a competent cells for transformation. Evenly spread it on the ampicillin-resistant LB solid culture plate, invert the plate, and culture it at 37°C overnight. Pick the white monoclonal colony, add it to the LB liquid culture medium containing ampicillin and shake it. Extract the plasmid DNA according to the plasmid extraction kit and sequence it. The sequencing primer is sqprimer: TGAGCGTCGATTTTTGTGATGCTCGTCAG. The sequencing results are as follows Figure 1 As shown, the sgRNA sequence was correctly inserted into the VK001-08 vector, and the position, direction and sequence of the inserted sequence were consistent with expectations, indicating that the VK001-08-sgRNA expression vector was successfully constructed.
[0035] 2. Construction of donor vector
[0036] 1. PCR amplification of gRNA-EF1α-puro-mCherry-polyA fragment Using the mCherry-puro plasmid as a template, PCR amplification was performed using primer pair HITI-F / R. The sequences of the primer pair HITI-F / R are shown in SEQ ID No. 2 and SEQ ID No. 3.
[0037] The reaction conditions are:
[0038]
[0039]
[0040] Table 2 HITI PCR primers
[0041]
[0042] Note: The bold part is the PAM sequence and exon sgRNA sequence, and the underlined part is the primer for amplifying large fragments.
[0043] After PCR, agarose gel electrophoresis was performed and the results were as follows Figure 2 As shown in the figure, the target band of the correct size was successfully obtained. The gel strip of the correct fragment size was cut off, and the target fragment was purified by gel recovery and set aside.
[0044] 2. Connect the target fragment to the pEASY-Blunt vector
[0045] Connect the PCR gel-recovered fragment obtained in step 1 to the pEASY-Blunt clonning vector. The reaction system is as follows:
[0046] PCR gel recovery product 4μL
[0047] pEASY-T1 Blunt Cloning Vector 1μL
[0048] Mix gently at 25℃ for 30min. After the reaction is complete, place the centrifuge tube on ice immediately for the next transformation. Spread the transformation product evenly on an ampicillin-resistant LB solid culture plate, invert the plate, and culture at 37℃ overnight. Pick a single clone colony and add it to the LB liquid culture medium containing ampicillin and shake it for 4-5h before sending it for sequencing. The sequencing results are as follows: Figure 3 As shown, it indicates that the donor fragment was successfully constructed.
[0049] 3. Establishment of DF-1 cell line with targeted insertion of exogenous genes into the PPARγ genome
[0050] 1. Co-transfect the Cas9-sgRNA expression vector and the donor vector into DF-1 cells. Observe the cell status and fluorescence expression under a microscope 48 hours after transfection. The expression of GFP protein indicates successful transfection. Figure 4 As shown, after 18 days of transfection, when the vector's own fluorescence disappears, the cells express red fluorescence, indicating successful gene editing. The red fluorescence positive rate was analyzed by flow cytometry, and the gene editing efficiency was 75.4%.
[0051] 2. Monoclonal cell screening and identification
[0052] DF-1 cells were sorted for monoclonal clones by flow cytometry, that is, one cell expressing red fluorescent protein was sorted from each well of a 96-well plate. The cells were cultured in a 37°C, 5% CO2 incubator and grown for 7 days. Fresh complete medium was replaced and continued to be cultured. When the cells grew to 90% confluence, they were serially passaged to a 6-well plate. The cells were further expanded and a portion of the cells was taken to extract the genome for identification. Primers at the 5' and 3' junctions were designed according to the position of the sgRNA and the inserted donor fragment (Table 3). The primer sequences are shown in SEQ ID No.4, SEQ ID No.5, SEQ ID No.6 and SEQ ID No.7. PCR amplification was performed using the genomic DNA of the transfected group and wild cells as templates. The PCR reaction conditions were: 94°C, 3min; 94°C, 30s, 60°C, 30s, 72°C, 50s, 35 cycles; 72°C, 7min; and stored at 4°C. The PCR product was subjected to agarose gel electrophoresis, as shown in Figure 5 As shown, PPARγ-F and PPARγ-5J-R were used to identify the 5' junction, and PPARγ-3J-F and PPARγ-R were used to identify the 3' junction. The target fragment was purified by gel recovery and connected to the pEASY-T1 simple cloning vector for transformation. A single clone was picked for positive PCR detection of bacterial liquid, and then sequenced. The sequencing results are shown in Figure 6 As shown, the foreign gene was successfully inserted into the PPARγ genome.
[0053] Table 3 Primers for identification of donors targeted for insertion into the 5′ and 3′ junctions of the PPARγ genome
[0054]
[0055] Use Beyotime RIPA lysis buffer to prepare samples and prepare 10% separation gel for protein separation. Add 5μL of protein Maker and 20μL of protein sample, pre-electrophoresis at 120V for 10min, then change to 100V and continue electrophoresis for 60min. After the electrophoresis, transfer the membrane at 200mA constant current for 1h. After the transfer, place the NC membrane in 5% skim milk powder for blocking at room temperature for 2h. Use Beyotime's primary antibody diluent to dilute the primary antibody (anti-PPARγ: 1:1000; anti-β-actin: 1:1000) according to the antibody instructions. Remove the NC membrane from the blocking solution, rinse it in PBST, and place it in the diluted primary antibody, incubate it overnight at 4℃. Dilute the HRP-labeled secondary antibody (goat anti-mouse, 1:5000) with 5% skim milk powder, place the NC membrane in the secondary antibody, and incubate it at room temperature for 1h. Discard the secondary antibody and wash it 3 times with PBST, 10min each time. According to the instructions of the ultra-sensitive ECL chemiluminescent solution of Haiji Gene Biology Company, the working solution was prepared (solution A: solution B = 1:1), and the working solution was used to cover the entire membrane. After incubation for 1 min, the membrane was placed in the gel imaging system for imaging and taking pictures. The results are as follows Figure 7 As shown, a PPARγ knockout cell line was successfully obtained.
Claims
1. A sgRNA for targeted knockout of chicken PPARγ gene, characterized in that: The sgRNA nucleotide sequence is shown in SEQ ID No.
1.
2. A recombinant vector, characterized in that: The vector comprises the sgRNA according to claim 1.
3. The recombinant vector according to claim 2, characterized in that The recombinant vector is a cas9 / gRNA vector.
4. Use of the sgRNA according to claim 1 or the recombinant vector according to claim 2 or 3 in targeted knockout of the chicken PPARγ gene.
5. A method for constructing a chicken PPARγ gene mutant cell line containing a red fluorescent marker, characterized in that: Here are the steps: S1. According to the sgRNA sequence for knocking out the chicken PPARγ gene, a reverse complementary nucleotide chain is designed and the two are mixed and annealed to form a double chain. The sgRNA nucleotide sequence is shown in SEQ ID No. 1; S2, connecting the double strand to the poultry cas9 / gRNA vector to obtain a recombinant vector; S3, using the mCherry-puro plasmid as a template, using the primer set HITI-F / R for PCR amplification, wherein the nucleotide sequences of the primer set HITI-F / R are shown in SEQ ID No.2 and SEQ ID No.3, respectively, and the PCR amplification product is gel-purified and then connected to the pEASY-Blunt vector to obtain a donor vector; S4. Co-transfect the recombinant vector and the donor vector into chicken-derived cells, and obtain a chicken PPARγ gene knockout cell line containing a red fluorescent marker through culture, screening and identification.
6. The method for constructing a chicken PPARγ gene mutant cell line containing a red fluorescent marker according to claim 5, characterized in that: In step S4, flow cytometry screening is performed using red fluorescence.
7. A cell line containing a red fluorescently labeled chicken PPARγ gene silenced by the construction method according to claim 5 or 6.
8. Use of a cell line according to claim 7 for specific labeling or tracing of PPARγ gene knockout cells when preparing gene-edited chickens.
Citation Information
Patent Citations
Red and green light switching type traffic signal lamp gene editing positive report enrichment system
CN116515904A
Mutation-independent gene knock-in therapy targeting 5' utr
US20240156985A1
